Table 2.
Demographic and disease characteristics of AML patients who provided samples
| ID# | Source | Status | Age (year)/Sex |
Blasts | Cytogenetics | FLT3 Status |
|---|---|---|---|---|---|---|
| 1 | PB | Relapsed | 29/F | 96% | Complex | ITD |
| 2 | PB | Newly diagnosed | 37/F | 36% | 46,XX,t(1;14)(p10q10) | ITD |
| 3 | PB | Newly diagnosed | 69/M | 20% | 46,XY, del(16)(q22) | ITD and D835 |
| 4 | PB | Newly diagnosed | 43/M | 48% | Complex | ITD |
| 5 | PB | Newly diagnosed | 83/M | 81% | 48,XY,+13 | ITD |
| 6 | PB | Newly diagnosed | 59/M | 21% | Complex | ITD |
| 7 | PB | Newly diagnosed | 32/M | 40% | 46,XY | ITD and D835 |
| 8 | PB | Relapsed/Refractory | 66/M | 39% | 46,XY | ITD |
| 9 | PB | Refractory | 67/M | 93% | Complex | WT |
PB, peripheral blood; WT, wild type